PRANA BIOTECHNOLOGY LTD's ticker is PRANXXXX and the CUSIP is 739727105. A total of 24 filers reported holding PRANA BIOTECHNOLOGY LTD in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $35,000 | -31.4% | 39,200 | -11.3% | 0.01% | -26.3% |
| Q2 2015 | $51,000 | +34.2% | 44,200 | +29.2% | 0.02% | +35.7% |
| Q1 2015 | $38,000 | -41.5% | 34,200 | -13.3% | 0.01% | -44.0% |
| Q4 2014 | $65,000 | -52.6% | 39,450 | -38.5% | 0.02% | -54.5% |
| Q3 2014 | $137,000 | -5.5% | 64,150 | 0.0% | 0.06% | -6.8% |
| Q2 2014 | $145,000 | -15.2% | 64,150 | +5.3% | 0.06% | -20.3% |
| Q1 2014 | $171,000 | -75.8% | 60,900 | -39.5% | 0.07% | -76.3% |
| Q4 2013 | $706,000 | – | 100,650 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | 109,342 | $98,000 | 0.11% |
| TWO SIGMA SECURITIES, LLC | 22,339 | $20,000 | 0.03% |
| Columbia Asset Management | 39,200 | $35,000 | 0.01% |
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 8,700 | $8,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 8,247 | $7,000 | 0.00% |
| Nine Chapters Capital Management LLC | 10,500 | $9,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 600 | $1,000 | 0.00% |
| DEUTSCHE BANK AG\ | 400 | $0 | 0.00% |
| MORGAN STANLEY | 19,525 | $17,000 | 0.00% |
| Citadel Advisors | 94,597 | $85,000 | 0.00% |